Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 163,372 | 37,280 |
| Other current assets | 0 | 0 | 19,250 | 5,672 |
| TOTAL | $0 | $0 | $182,622 | $42,952 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 0 | 0 | 72 | 87 |
| TOTAL | $N/A | $N/A | $72 | $87 |
| Total Assets | $0 | $0 | $182,833 | $43,039 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 3,094 | 293 |
| Accrued Expenses | 0 | 0 | 5,138 | 1,525 |
| TOTAL | $0 | $0 | $8,360 | $1,818 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $8,371 | $1,818 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | -88,512 | -51,606 |
| Other shareholders' equity | 0 | 0 | 259,571 | 89,863 |
| TOTAL | $0 | $0 | $174,462 | $41,221 |
| Total Liabilities And Equity | $0 | $0 | $182,833 | $43,039 |